Physician profile
Scott Lipson
NPI 1285676916
$8,768.70
in general payments reported to CMS, 2019-2025
13 companies · $549 in 2025
The $549 reported for 2025 was more than what 80% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,360 · 2020: $489 · 2021: $132 · 2022: $68.38 · 2023: $3,258 · 2024: $912 · 2025: $549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,909 · Food and Beverage: $1,810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,909.31 |
| Food and Beverage | $1,809.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,967.48 | 2019-2024 | |
| Evolution Surgical, INC | $1,566.53 | 2022-2025 | |
| Linvatec Corporation | $1,057.00 | 2019-2023 | Biobrace 23mm |
| Sequoia Surgical, INC. | $1,037.63 | 2019-2020 | |
| Stryker Corporation | $533.60 | 2019-2025 | Blueprint Patient Specific Instrumentation |
| Bioventus LLC | $213.96 | 2020-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $180.66 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $106.18 | 2023 | |
| Depuy Synthes Sales INC. | $32.50 | 2019 | |
| Boston Scientific Corporation | $26.06 | 2025 | Wavewriter Alpha Prime 16 |
| Mindray Ds USA, INC. | $16.70 | 2023 | A7 Anesthesia System |
| Axogen | $15.28 | 2019 | |
| Endo Pharmaceuticals INC. | $15.12 | 2023 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Lipson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.